Professional Documents
Culture Documents
Evolution and Prognosis of Necrotic Primary Teeth After Pulpectomy
Evolution and Prognosis of Necrotic Primary Teeth After Pulpectomy
Research Article
_______________________________________________________________________________________________________________________________________________________________
Introduction
The introduction of formaldehyde into endodontic therapy
with Gysis trio-paste in 1899, supporting the concept of fixing
the pulp and leaving it sterile, allowed the possibility of pulp
treatment in primary teeth. However, it was Buckley,1 in 1904,
who used formaldehyde to treat pulp necrosis by introducing a
formula containing 40% formaldehyde, tricresol, and glycerin.
After Buckleys1 use of formaldehyde, pulp tissue removal
was performed by root canal instrumentation and filling with
resorbable pastes: Walkhoffs iodoform paste (Kri-1a),2-7 zincoxide eugenol (ZOE),7-10 and calcium hydroxide,9 as well as different combinations: iodoform + ZOE + calcium hydroxide,11
50% iodoform + 50% camphorated paramonochlorophenol,12
30.3% calcium hydroxide + 40.4% iodoform + 22.4% silicone oil
+ 6.9% inert material10,13-14 (Vitapexb).
In 1989, a procedure was published15 for root canal preparation and filling in necrotic temporary molars with a paste made
of Kri-1 (80.8% iodoform, 2.025% parachlorophenol, 1.21%
menthol, 4.86% camphor and 15 g of excipient), Tiffel/20%
tricresol, 20% formol, 20% eugenol, 6% eucalyptol and 100 g
of excipient) and pure calcium hydroxide, obtaining a high
percentage of success, with remission of all symptoms. This
was the first publication in which formaldehyde was mentioned
as a component of root canal filling material, thus partly
recovering Buckleys formula, which contained 40% formaldehyde and glycerine.
Since 1998 onwards, tricresol, a mixture of three isomers
(orthocresol, metacresol and paracresol), was substituted by
metacresol, the most innocuous ionomer in tricresol, due to the
possible side effects the former. Thus, the following formula
has been used since then:
- Metacresol
- Formaldehyde
- Eucalyptol
- Excipient
20 mg
20 mg
6 mg
100 mg
Formaldehyde, like other aldehydes, quickly binds to organic substance, thus originating albumin-formaldehyde with
high permeability and penetration capacity. It is metabolized in
acid form, carbon dioxide and amino acid radicals, and its biodegradation fundamentally occurs at the hepatic level and, to a
lower extent, at pulmonary and renal levels.16
When metabolized, part of the drug fixes on different body
tissues (mainly liver and kidney), although only 1% of the dose
applied in each tooth is usually absorbed, a diluted formaldehyde formulation has been recommended.17
Another side effect of formalin-cresol is its antigenic
potential18 and, although it is not considered toxic at low exposure levels, the literature contains cases of hecromatosis, dermatitis and pulmonary pathology (asthma) in workers of paper,
cosmetic and wood-derivative industries.
The use of pure calcium hydroxide with approximate pH
12.75 neutralizes the acid environment generated by tissue
necrosis by means of its antibacterial effect.19-20 However,
some21 consider that its antibacterial action is influenced by the
liberation of hydroxyl ions and enzyme inactivation in the
bacterial cytoplasmatic membrane.
Another property attributed to calcium hydroxide is its
reducing effect on inflammatory responses and its role in detritus dissolution22,23 of necrotic tissue which may remain on
canal walls after canal instrumentation and washing.
Likewise, Walkhoffs iodoform paste (Kri-1), also has
different properties which makes it beneficial for treatment of
necrotic teeth.
Inge4 reported that iodoform pastes do not produce tissue
irritation (even in case of material extrusion into the periapical
area), stops secretion and its antiseptic effect is long-lasting.
Held3 stated that, although iodoform did not have a direct
effect on tooth germ, it slowed down germ growth, also attributing it certain hemostatic effect in capillaries, while its
slightly irritating action stimulated tissue proliferation and
leukocyte migration.
In general, most authors2,5-7,24 emphasized positive factors
After periapical radiograph, anesthesia and rubber dam isolation, the pulp chamber was accessed, and the root canals were
instrumented with Kerrs files sectioned at 18 mm (2 mm on
the tip) in order to avoid apical perforation; the canals were
rinsed with 5% sodium hypochlorite and dried with cotton and
paper tips. Then, the canals were filled with the iodoform paste
and the tooth restored with a stainless steel crown.
All teeth were clinically and radiographically examined at 6
months, 18 and 30 months ( 1 month). All treatments were
performed by one single operator.
For the study, furcation radiolucency was scored as 0 if it
showed no image, + when radiolucency covered less than a
third of the furcation size, ++ with radiolucency ranging between 1/3 and 2/3 of the furcation size, and +++ when radiolucency was over 2/3 of the furcation size but remained over the
permanent tooths germ without affecting the tooth. In the
periapical area, radiolucency was scored in the same way, considering one third, two thirds and three thirds of the distance
between the primary tooths apex and permanent tooth germ.
Eruption time of the permanent tooth was compared with
the contralateral untreated tooth.
Statistical analysis - Chi-square statistical test and Cramers V
as measure of association were used to compare differences in
the distribution of the different variables studied or association
between variables, respectively. Tests with P< 0.001 were
considered significant. Likewise, estimation of means and
standard deviations were performed for quantitative variables,
while estimation of confidence intervals and a test for proportion comparison were completed.
Results
Evolution of pain, inflammation and swelling - Pain in 138
teeth (44.3%), inflammation in 159 teeth (51.6%) and abscess
in 79 teeth (25.6%), resolved in 100% of the cases after the first
recall.
Evolution of radiolucency - Out of the 250 teeth with radiolucency at treatment onset, 222 (171 + 25 + 26) became 0, thus
representing 88.8% and 95% (0.85-0.93%) after 3 years.
Two hundred thirty eight (171 + 25 + 26 + 4 + 12) teeth had
radiolucency completely resolved in the first recall, thus
representing 93.5% (P< 0.05, 0.94-0.98%) and only 10 of them
still showed radiolucency ++.
Out of the 250 teeth with radiolucency at treatment onset,
radiolucency was found in only 26 of them with a level of
10.4% and 2 of them remained with ++ levels in the last recall.
Evolution of external root resorption - Out of the 18 teeth with
external resorption at treatment onset, eight of them showed no
signs after the first recall, thus representing 44.4% (P< 0.05,
24.6-66.3%).
Out of the 18 teeth with external root resorption at treatment
onset, 16 of them stopped showing it after the last recall, thus
representing 88.9% (P< 0.05, 0-15%).
Evolution of internal root resorption after the first recall - Out
of the eight teeth with internal root resorption, seven of them
showed resolution after the first recall (87.5%).
Association between eruption and radiolucency Radiolucency
favored premature eruption of permanent teeth.
Fig. 1. Bone resorption in the furcation area in the second primary molar. A. Before, B. Immediately after, C. 6 months after pulpectomy
treatment. Radiolucency in the furcation area was resolved.
Fig. 2. Furcation radiolucency in the second primary molar. A. Before, B. Immediately after pulpectomy, C. 6 months after the pulpectomy
treatment/ Notice the resolution of the furcation radiolucency.
Discussion
In a previous study14 completed by our group, in which
pulpectomies were performed in a single session by using the
same procedure and filling material but in which we also performed furcation biopsies both pre- and post-treatment (6, 9 and
between 17 and 24 months after treatment onset), it was noticed
that, in pre-treatment biopsy, 83.5% of the sample showed
granulation tissue while 16% showed necrotic bone, medullar
fibrosis and other degenerative signs. Six months after treatment onset, 60% of cases showed an image similar to the
previous one; however, 17-24 months after treatment onset,
100% showed mature bone, 75% showed medullar fibrosis,
50% showed necrosis and degenerative signs, and 25% showed
new bone formation.
Appearance of osteoid tissue pointed out the existence of
bone formation and a certain attempt at complete regeneration,
References
1. Buckley JP. A rational treatment on putrescent pulps. Dent Res 1904;11931197.
2. Castagnola L, Orlay HG. Treatment of gangrene of the pulp by the
Walkhoff method. Br Dent J 1952;93:93-102.
3. Held AJ. Is iodoform abandoned? Schweiz Msew 1964;74:715-735 (In
French).
4. Juge H. Resorbable pastes for canal fillings. Int Dent J 1959;9:461-476.
5. Castagnola L, Wirz J. The use of iodoform paste (Walkhoff method) in
modern endodontic therapy. Quintessence Int 1976;7:19-23.
6. Garca-Godoy F. Evaluation of an iodoform past in root canal therapy for
infected primary teeth. ASDC J Dent Child 1987; 54: 30-34.
7. Wright KJ, Barbosa SV, Araki K, Spangberg LS. In vitro antimicrobial and
cytotoxic effects of Kri-1 paste and zinc oxide-eugenol used in primary
tooth pulpectomies. Pediatr Dent 1994;16:102-106.
8. Primosch RE, Ahmad A, Setzer B, Guelmann M. A retrospective
assessment of zinc oxide-eugenol pulpectomies in vital maxillary primary
incisors successfully restored with composite resin crowns. Pediatr Dent
2005;27:470-477.
9. Ozalp N, Saroglu I, Sonmez H. Evaluation of various root-canal filling
materials in primary molar pulpectomies: An in vivo study. Am J Dent
2005;18:347-350.
10. Mortazavi M, Mesbahi M. Comparison of zinc oxide, and Vitapex for root
canal treatment of necrotic primary teeth. Pediatr Dent 2004;14:417-424.
11. Muruzabal M, Erausquin J, Devoto FH. A study of periapical overfilling in
root canal treatment in the molar of rat. Arch Oral Biol 1966;11:373-383.
12. Cerqueira DF, Mello-Moura AC, Santos EM, Guedes-Pinto AC.
Cytotoxicity, histopathological, microbiological and clinical aspects of an
endodontic iodoform-based paste used in pediatric dentistry: A review. J
Clin Pediatr Dent 2008;32:105-110.
13. Nurko C, Ranly DM, Garca-Godoy F, Lakshmyya KN. Resorption of a
calcium hydroxide/iodoform paste (Vitapex) in root canal therapy for
primary teeth: A case report. Pediatr Dent 2000;22:517-520.
14. Amorin L de F, Toledo OA, Estrela CR, Decurcio D de A, Estrela C.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately.